| Identification | Back Directory | [Name]
5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide | [CAS]
56290-94-9 | [Synonyms]
RMI-81968
Medroxalol
5-[2-[4-(1,3-benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamide
5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
5-[2-[[3-(1,3-Benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxybenzamide
Benzamide, 5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]-2-hydroxy- | [EINECS(EC#)]
260-099-3 | [Molecular Formula]
C20H24N2O5 | [MOL File]
56290-94-9.mol | [Molecular Weight]
372.42 |
| Hazard Information | Back Directory | [Uses]
Antihypertensive. | [Uses]
Medroxalol is an antihypertensive agent that possesses both alpha and beta-adrenergic antagonistic properties. Medroxalol is used to treat mild and moderate hypertension. | [Definition]
ChEBI: Medroxalol is a member of salicylamides. | [in vivo]
Medroxalol (oral gavage; 12.5-50 mg/kg; once daily; 12 d) treatment shows antihypertensive activity in spontaneously hypertensive rats[1]. | Animal Model: | Male spontaneously hypertensive rats (SHR)[1] | | Dosage: | 12.5, 25, or 50 mg/kg | | Administration: | Oral gavage; 12.5, 25, or 50 mg/kg; once daily; 12 days | | Result: | Produced a dose-related fall in blood pressure. |
| [storage]
Store at -20°C |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
Leancare Ltd.
|
| Tel: |
+33 962096793 |
| Website: |
www.leancare.co.uk |
|